The best studied oncogenic mechanisms are inactivating defects in both alleles of tumor suppressor genes and activating mutations in oncogenes. Chromosomal gains and losses are frequent in human tumors, but for many regions, like 1p36 and 17q in neuroblastoma, no mutated tumor suppressor genes or oncogenes were identified. Amplification of N-myc in neuroblastoma is strongly correlated with loss of 1p36 and gain of 17q. Here we report that N-myc downregulates the mRNA expression of many genes with a role in cell architecture. One of them is the 1p36 gene Cdc42.
Introduction
Neuroblastoma is a childhood tumor originating from neural crestderived cells. Approximately 20% of neuroblastomas have N-myc amplification, which is usually accompanied by loss of heterozygosity of distal chromosome 1p and additional copies of chromosome 17q (1) . Deletions of the short arm of chromosome 1 in N-myc amplified neuroblastomas are typically very large. The shortest 1p deletion we observed in a series of N-myc amplified neuroblastomas was 24.4 Mb, from the telomere till the RUNX3 gene (ref. 2; http://genome.cse.ucsc.edu). The region is deleted in 90% to 95% of all N-myc amplified tumors, whereas about 5% of N-myc amplified neuroblastomas have no apparent 1p deletions. In addition, N-myc single copy neuroblastomas can have 1p deletions. These deletions are of variable length as well, but can be smaller with a more telomeric SRO (3, 4) . The different SROs in N-myc-amplified neuroblastomas have raised the idea that more than one tumor suppressor gene maps on distal chromosome 1p (5) .
N-myc-amplified neuroblastomas follow a very aggressive course (6) . Overexpression of transfected N-myc genes in neuroblastoma cell lines strongly increased proliferation rates (7, 8) . Recent mRNA expression profiling experiments, serial analysis of gene expression (SAGE) and microarray analysis, identified many myc-regulated genes (9) (10) (11) (12) (13) . We used SAGE to identify genes regulated by N-myc in neuroblastoma. Genes up-regulated by N-myc were involved in rRNA processing and protein synthesis (9) . Two recently identified N-myc targets, nm23-H1 and nm23-H2, map to chromosomal band 17q21, in the chromosome 17q region overrepresented in neuroblastoma (14) .
Additional copies of the distal chromosome 17q arm are present in about 70% of neuroblastoma tumors, including all N-myc amplified cases. The copy number ranges between two and eight extra alleles and the minimal region of gain is 17q21-17qter. The map position of the nm23-H1 and nm23-H2 genes at 17q21 makes them interesting candidates for a role in neuroblastoma pathogenesis. The nm23 proteins encode nucleoside diphosphate kinases, the suppliers of nucleoside triphosphates. In several human tumors, like breast cancer and melanoma, decreased expression was correlated with poor prognosis (15, 16) . Upregulation of nm23-H1 reverted melanoma cells from metastatic to nonmetastatic (17) . In contrast, in several other tumors including neuroblastoma and osteosarcoma, elevated expression of nm23-H1 and nm23-H2 was associated with a poor prognosis (18, 19) . The extra copies of 17q and the induction by N-myc result in a strongly increased expression of the nm23 genes in neuroblastoma cell lines and tumors (14) . Besides the function of the nm23 proteins as dinucleoside kinases, growing evidence exists for additional functions in signal transduction (20) (21) (22) .
In this article, we identified genes down-regulated by N-myc in neuroblastoma. One of the key genes is Cdc42. The Cdc42 gene maps on 1p36, and one copy is consistently deleted in N-myc amplified neuroblastoma. In addition, we provide evidence that the activity of the Cdc42 protein is down-regulated by nm23-H1 and nm23-H2, which are induced by N-myc.
Materials and Methods
Cell culture. The SHEP-2 and SHEP-21N cell lines were cultured in RPMI, the SKNAS-NmycER cells in DMEM. Both media were supplemented with 10% FCS, 2 mmol/L glutamine, 50 units/mL penicillin, and 50 units/ mL streptomycin. N-myc expression in SHEP-21N was repressed by tetracycline ( final concentration, 50 ng/mL; Sigma, St. Louis, MO). The NmycER protein in the SKNAS-NmycER cells was activated upon addition of 4-hydroxytamoxifen ( final concentration, 50 nmol/L; Sigma). The ER domain has a point mutation, which enables transactivation of the chimearic protein by 4-hydroxytamoxifen and not estrogens (23) .
Plasmids. The pCdc42flag plasmid was constructed by amplification of cDNA with primers Cdc42Efor (5V -TATATAGAATTCATTTCAGCAATGCA-GACAATTAAG-3V ) and Cdc42Xrev (5V -TATATACTCGAGTAGCAGCACA-CACCTGCG-3V ). The amplified product was digested with EcoRI and XhoI and cloned into the EcoRI and XhoI sites of pCMV-Tag4 vector (Stratagene, La Jolla, CA). The pCdc42G12Vflag and pCdc42T17Nflag constructs were produced by amplification of Cdc42 from vector pCdc42flag using primer T3 (5V -AATTAACCCTCACTAAAGGG-3V ) in combination with mutant primers CdcG12Vrev (5V -GTGTAGGATATCAGGAGACATGTTTTACCAA-CAGCAACATCGC-3V ) or CdcT17Nrev (5V -GTGTAGGATATCAGGAGA-CAGTTTTTACC-3V ). The PCR products were digested with BamHI and EcoRV and ligated in the BamHI and EcoRV sites of pCdc42flag vector.
Northern blot analysis. Total RNA (20 Ag per lane) was separated on a 1% agarose gel in the presence of 6.7% formaldehyde and blotted on Hybond-N membranes (Amersham, Piscataway, NJ) in 10Â SSC. Hybridization was carried out overnight in 0.5 mol/L NaHPO 4 (pH 7.0), 7% SDS, 1 mmol/L EDTA at 65jC. Filters were washed in 40 mmol/L NaHPO 4 , 1% SDS at 65jC. Probes were labeled by random priming of sequence-verified PCR products.
Western blotting. Primary antibodies: anti-N-myc (PharMingen, San Diego, CA), anti-Cdc42-B8 (Santa Cruz Biotechnology, Santa Cruz, CA), anti--tubulin (Roche, Nutley, NJ), anti-Caspase-3 (Cell Signaling Technology, Beverly, MA), and anti-poly(ADP-ribose) polymerase (Biomol Research Labs, Plymouth Meeting, PA). Western blotting was done according to standard procedures, secondary antibody anti-mouse linked to horseradish peroxidase (Amersham), detected with Enhanced Chemiluminescence KIT (Amersham).
Transient transfection and immunofluoresence microscopy. For transient expression, the cells were grown for 48 hours on glass slides in medium supplemented with 1% FCS. Four micrograms of plasmid DNA and 4 AL DAC-30 (Eurogentec, Seraing, Belgium) in 1 mL medium, without FCS and antibiotics, was incubated for 30 minutes at room temperature. For double transfections, 4 Ag of each plasmid were incubated with 8 Ag DAC-30. The DNA/DAC-30 mix was added dropwise to the cell cultures. After 16 hours, the medium was replaced by fresh medium with 1% FCS. Forty hours after transfection, the slides were fixed with 4% paraformaldehyde in PBS for 25 minutes. The cells were permeabilized with PBS/0.05% Triton X-100. The slides were washed thrice with PBS/TX (PBS, 0.01% Triton X-100). The slides were blocked for 30 minutes in Abdil (PBS, 0.01% Triton X-100, 1% bovine serum albumin). The antibodies were diluted in Abdil each incubated for 30 minutes each incubation followed by four washes in PBS/ TX. Antibodies: 400 times diluted mouse-anti-flag M2 (Stratagene), 100 times diluted TRITC-or FITC-conjugated anti-mouse (Sigma), 200 times diluted goat-anti-NFL (Santa Cruz Biotechnology), and 200 times diluted TRITC-conjugated anti-goat (Sigma). The slides were rinsed with H 2 O, dried and mounted in Vectashield (Vector Laboratories, Burlingame, CA) with 4V ,6-diamidino-2-phenylindole (nuclear staining).
Glutathione S-transferase pulldown. Nm23H1 was amplfied with adaptor oligonucleotides (5V -TATATAGGATCCATGGCCAACTGTGAGCG-TAC-3V and 5V -TATATGAATTCTCTGCCCTCCTGTCATTCAT-3V ). The product was digested with BamHI/EcoRI and cloned in the pGEX2TK vector (Pharmacia, Piscataway, NJ) to yield GST-nm23H1.
GST-nm23H1 transformed bacteria were lysed in PBS-0.01%Triton X-100. Cell lysis and pulldown were done as described by Sander et al. (24) .
RNA interference. The sequences of the single stranded RNA molecules (Isogen, Maarsen, The Netherlands) are for Cdc42-a 5V -CUAUGCAGU-CACAGUUAUGTT-3Vand 5V -CAUACCUGUGACUGCAUAGTT-3V , for Cdc42-b 5V -CUCACCACUGUCCAAAGACTT-3V and 5V -GUCUUUGGACAGUGGUGAG-TT-3V , for N-myc-a 5V -CACCAAGGCUGUCACCACATT-3Vand 5V -UGUGGU-GACAGCCUUGGUGTT-3V , for N-myc-b 5V -CCCAGACCUCGAGUUUGACTT3Vand 5V -GUCAAACUCGAGGUCUGGGTT-3V , and for GFP 5V -GACCCGCGC-CGAGGUGAAGTT-3V and 3V -CUUCACCUCGGCGCGGGUCTT-3V .
Cells were grown to 30% confluency in 6-cm plates. RNA interference was done as described by Elbashir et al. (25) . In short, 20 Amol/L per single stranded RNA molecule in 30 AL annealing buffer [0.1 mol/L KAc, 30 mmol/L HEPES/KOH (pH 7.4), and 2 mmol/L MgAc] was heated at 95jC for 5 minutes, followed by incubation at 37jC for 1 hour. The small interfering RNA (siRNA) mixture was transfected serum-free with 30 AL Lipofectamine (Invitrogen, Carlsbad, CA) as described by the manufacturer. After 4 hours, the medium was supplemented with FCS to a final concentration of 10%.
For immunofluorescence analysis cells were grown on glass slides in 6-well plates and transfected with 15 AL siRNA and 15 AL Lipofectamine. After 72 hours, the cells were fixed with formaldehyde and stained with TRITC-phalloidin (Sigma) and 4V ,6-diamidino-2-phenylindole.
Results
Genes down-regulated by N-myc. We have applied the SAGE technique to identify downstream target genes of N-myc. The neuroblastoma cell line SHEP has no N-myc amplification and expression. A tetracycline-regulated N-myc expression vector has been introduced into these cells, resulting in the SHEP-21N clone (8) . SAGE libraries were constructed from N-myc expressing SHEP-21N cells and from SHEP-2 (empty vector control) cells (9) . We identified 34,443 tags for SHEP-21N and 44,450 tags for SHEP-2, each representing one mRNA expressed in these cells. 112 Tags were significantly (P < 0.01) down-regulated in the N-myc expressing cells. We could reliably assign 78 of these tags to a total of 64 genes (http://bioinfo.amc.uva.nl/HTMseq/controller; Table 1 ). We analyzed 14 genes by Northern blot, which confirmed the SAGE data (Fig. 1A) . The overall expression pattern showed that N-myc down-regulates many genes involved in the architecture of the cell and the extracellular matrix. Cytoskeletal components like h-actin and vimentin are downregulated, but also genes which regulate the structures, like transgelin (TAGLN). The adhesion properties of cells depend on the extracellular matrix and membrane molecules. Genes of both groups are repressed by N-myc. Several collagens are regulated by N-myc, but also connective tissue growth factor (CTGF) and SPARC, which regulate the build-up of the extracellular matrix. In addition, cadherin 11 (CDH11) and other genes encoding membrane proteins are down-regulated.
To investigate whether the genes were indeed down-regulated by N-myc, we did Northern blot analysis of a time course experiment in which N-myc was switched off and on in the SHEP-21N cell line. The N-myc expression was switched off by tetracycline for 7 days, after which N-myc was switched on for another 7 days (Fig. 1B) . Two distinct patterns of N-myc regulation emerged. Expression of a limited number of genes increased within 24 hours after N-myc was turned off. This group includes galectin-1 (LGALS), S100A10, and caveolin-1 (CAV1; Fig. 1B) . Reexpression of N-myc decreased the expression of these genes (Fig. 1B) . The majority of genes follow a slow N-myc dependent regulation. The expression of COL1A1, TAGLN, SPARC, FN1, and SDC2 increased 4 days after N-myc was switched off (Fig. 1B ). These analyses show that genes involved in cell architecture and adhesion are important targets of downregulation by N-myc. Most of these genes are slowly regulated and thus most likely represent secondary targets.
Cdc42 expression is down-regulated by N-myc. One of the genes identified as an N-myc downstream target is Cdc42 ( Table 1) . The SAGE-tag frequencies show that Cdc42 is expressed at a level of 12.6 mRNAs per 20,000 mRNAs in SHEP-2 and 2.9 per 20,000 in SHEP-21N. Cdc42 is a member of the Rho GTPase subfamily and functions in a series of signaling pathways, which are particularly important in cytoskeletal remodeling (26, 27) . As many genes with a function in these processes are down-regulated by N-myc, Cdc42 might be a key target of N-myc to control cytoskeletal remodeling. Northern blot analysis confirmed the decreased expression of N-myc, Cdc42, and nm23 Cooperate in Neuroblastoma www.aacrjournals.org Cdc42 mRNA in SHEP-21N compared with SHEP-2 ( Fig. 2A) . When N-myc expression in SHEP-21N was down-regulated by tetracycline, Cdc42 mRNA expression increased within 24 hours ( Fig. 2A) . Western blot analysis showed that also the Cdc42 protein level increased after N-myc was switched off (Fig. 2B) . The regulation of Cdc42 was also investigated in cell line SKNASNmycER, which expresses a hybrid N-myc-estrogen receptor protein that can be activated by 4-hydroxytamoxifen. The SKNAS-NmycER cells were treated with 4-hydroxytamoxifen and the Cdc42 mRNA expression decreased within 24 hours after N-myc activation (Fig. 2C) . The Cdc42 reduction was moderate (3-fold). In addition, we analyzed the expression of Cdc42 mRNA in a panel of neuroblastoma tumors by Northern blot. Cdc42 expression was reduced in 10 tumors with N-myc amplification compared with 10 N-myc single copy tumors (Fig. 2D) . The tumors show no expression of c-myc (Fig. 2D) . We conclude that Cdc42 mRNA expression in neuroblastoma cells is down-regulated by N-myc, resulting in decreased Cdc42 protein levels.
The Cdc42 gene maps at 21.5 Mb from the 1p telomere, within the 24.4 Mb region consistently deleted in N-myc amplified neuroblastomas (2) . The net result is that Cdc42 is 50% reduced by deletion of one allele in N-myc amplified neuroblastoma tumors, and the expression is further down-regulated by N-myc.
We therefore analyzed whether Cdc42 could function as a tumor suppressor gene in neuroblastoma.
Activated Cdc42 induces neuronal differentiation in SHEP-21N cells. Cdc42 is a G-protein that is active in the GTP-bound state and inactive in the GDP-bound state. We investigated the role of Cdc42 in neuroblastoma by transient expression of the Cdc42 protein coupled to a COOH-terminal FLAG tag (Cdc42flag). We first transfected a mutant Cdc42 form that is permanently active (Cdc42-G12V). After 40 hours, 42% of the SHEP-21N cells expressing the Cdc42-G12Vflag protein showed neuronal differentiation, as evident by long neurite extensions of at least twice the length of the cell body (Fig. 3A and B) . The extensions were analyzed for expression of neurofilament, a marker for neuronal differentiation. The extensions in cells transfected with Cdc42-G12V show formation of neural fibers with strong expression of the neurofilament light chain (Fig. 3C) . The differentiation was not observed in untransfected cells. In addition, we transfected SHEP-21N with a wild-type Cdc42flag construct and with a dominantnegative Cdc42 mutant (Cdc42-T17N). Wild-type Cdc42flag and the dominant-negative Cdc42-T17Nflag-transfected cells showed only 3% and 6% differentiation, respectively (Fig. 3A and B) , suggesting that the wild-type Cdc42 protein in SHEP-21N cells is in the inactive GDP-bound state. However, when N-myc was switched off with tetracycline, also wild-type Cdc42flag-transfected cells displayed neuronal differentiation (28%), whereas the dominantnegative Cdc42 construct remained inactive (Fig. 3B ). This strongly suggests that N-myc not only down-regulates the Cdc42 mRNA expression level but also keeps the Cdc42 protein in its inactive GDP-bound form. Nm23 suppresses the activity of Cdc42. Cycling between the inactive GDP-bound and active GTP-bound state of Cdc42 is regulated by GTPase-activating proteins (GAP) and guanine nucleotide exchange factors. The inhibition of Cdc42-induced differentiation by N-myc indicated that N-myc controls a GAP or guanine nucleotide exchange factor of Cdc42. Previous experiments have shown that N-myc strongly up-regulates the expression of the nm23-H1 and nm23-H2 genes in SHEP-21N (14) . We confirmed the up-regulation of the nm23-H1 gene in the SKNAS-NmycER cell line treated with 4-hydroxytamoxifen (Fig. 2C) . In addition, in tumors with N-myc amplification, nm23-H1 is also highly expressed (Fig. 2D) .
Nm23 proteins are primarily known to function as dinucleoside kinases, but a possible role for nm23-H1 in GDP and GTP exchange of Rad1 has been reported (20) . We investigated whether the nm23-H1 and Cdc42 proteins can physically interact with each other. For this purpose, we constructed the glutathione S-transferase (GST) fusion protein GST-nm23-H1. The GST-nm23-H1 protein was immobilized on glutationesepharose beads and incubated with a lysate of SHEP-21N cells transfected with Cdc42. The beads were analyzed for bound proteins by Western blot. Cdc42 was pulled down by the GSTnm23-H1 protein and not by the GST protein alone (Fig. 3D) . As a control for unspecific protein binding in the pull-down assay, the Western blots were incubated with an N-myc antibody. Nmyc did not bind to the GST or GST-nm23-H1 protein (Fig. 3D) . We concluded that nm23-H1 and Cdc42 can physically interact.
We also analyzed the functional interaction of nm23-H1 and nm23-H2 with Cdc42. Transient transfection of a wild-type Cdc42-flag construct into SHEP-21N cells resulted in 8% differentiation of the transfected cells (Fig. 3E) . When N-myc was switched off in this experiment, the Cdc42flag-induced differentiation increased to 20% of the transfected cells. As Nmyc down-regulation resulted in a decrease of nm23-H1 and nm23-H2, we reconstituted these proteins by cotransfections. SHEP-21N cells in which N-myc expression was switched off by tetracycline were cotransfected with wild-type Cdc42flag and nm23-H1 and/or nm23-H2 expression vectors. Cotransfection of either nm23-H1 or nm23-H2 could completely replace the effect of N-myc, as the differentiation reduced from 20% to 6% (Fig. 3E) . The percentage of differentiated cells is not further reduced by transfection of both nm23-H1 and nm23-H2. Therefore, nm23-H1 and nm23-H2 prevent Cdc42-induced differentiation. As N-myc strongly up-regulates nm23-H1 and nm23-H2, they are likely to mediate the effect of N-myc.
Cdc42 RNA interference: Cdc42 is essential for cell division. Neuroblastomas with N-myc amplification still have one Cdc42 allele. The classic paradigm for tumor suppressor gene inactivation is deletion of one copy and mutation of the second allele. We screened the coding region of Cdc42 for mutations in over 50 neuroblastoma tumors and cell lines but no mutations were found. The Cdc42 expression in N-myc amplified tumors suggests haplo-insufficiency as a potential mechanism for tumorigenesis. We further decreased the expression of Cdc42 by RNA interference. The effect of two Cdc42-specific siRNAs was compared with two N-myc-siRNAs, and siRNA for green fluorescent protein, which has no target in the SHEP-21N cells. Western blot and Northern blot analysis showed that 48 hours after transfection the expression of N-myc or Cdc42 was strongly reduced by N-myc-siRNA and Cdc42-siRNA, respectively ( (Fig. 4C ). Silencing of Cdc42 had an even more dramatic effect on cell growth. The majority of SHEP-21N cells treated with Cdc42-siRNA died within 72 hours after transfection (Fig. 4C) . In contrast, cells treated with gfp-or N-myc-siRNA survived the treatment. The experiments were repeated on glass slides and the actin cytoskeleton and nuclei were stained 72 hours after transfection. In the absence of Cdc42, the actin was organized in a peripheral membrane-associated ring, indicating that these cells were unable to rearrange the cytoskeleton after cell division (Fig. 4D) . The cells transfected with Cdc42-siRNA showed 16% apoptotic nuclei, compared with 2% and 5% in the gfp-siRNA and N-myc-siRNA-treated cells, respectively (Fig. 4E) . The apoptosis was further analyzed on Western blot. The cells were treated for 48 hours with siRNAs and the lysates were screened for cleaved proteins. In cells treated with Cdc42-siRNAs, both caspase3 and poly(ADP-ribose) polymerase showed the apoptosis-induced cleavage products (Fig. 4F) . No cleaved products were visible after treatment with gfp-or N-myc-siRNA. Therefore, Cdc42 is an essential gene for the growth and survival of neuroblastoma cells. This provides an explanation for the absence of Cdc42 mutations: a minimal amount of Cdc42 is required for cell survival.
Discussion
Cellular transformation involves increased proliferation, alterations in cell shape and adhesion. The N-myc protein regulates genes involved in these processes. Here, we have shown that Nmyc represses genes determining the cell structure. The N-myc targets include structural genes but also one of the key regulators Cdc42. Cdc42 is a member of the Rho GTPase subfamily and functions in a series of signaling pathways, which are particularly important in cytoskeletal remodeling (26, 27) . It has a major role in actin reorganization, as Cdc42-GTP binds to WASP, which in turn binds and activates the Arp2/3 complex (28). This induces the branching of actin filaments and the formation of the cytoskeleton. Several genes functioning in this process are regulated by N-myc. N-myc not only downregulates Cdc42, but also actin (ACTG1 and ACTB) and ARPC1B (Table 1) . Furthermore, Cdc42 has been shown to mediate laminin-dependent differentiation in PC12 cells and murine neuroblastoma cells (29) (30) (31) . Here, we have shown that reconstitution of active Cdc42 allowed differentiation of human neuroblastoma cells. The Cdc42 expression and activity is down-regulated at three different levels in N-myc amplified neuroblastoma cells (Fig. 5) . First, the expression is 50% reduced by loss of heterozygosity of 1p36, as it maps in the 1p region consistently deleted in N-myc amplified neuroblastomas. Second, a further 4-to 5-fold down-regulation of Cdc42 mRNA is caused by the overexpression of N-myc. Together, this results in an estimated 8-to 10-fold down-regulation at the mRNA level. Third, N-myc inhibits the differentiation induced by the Cdc42 protein. This effect of N-myc is fully reconstituted by transfection of nm23-H1 and nm23-H2 constructs, which strongly suggests that the N-myc effect is mediated by the nm23 proteins.
Regulation of the nm23-H1 and nm23-H2 genes in neuroblastoma is a mirror image of the Cdc42 regulation. The nm23 genes map in the minimal region of 17q gain and are present with two to eight extra copies. The expression of these nm23 copies is 6-to 10-fold up-regulated by N-myc, resulting in a 12-to 80-fold overexpression of nm23-H1 and -H2 (14) . Therefore, the ratio between Cdc42 and nm23 protein levels is probably at least 100-fold out of balance. The differentiation-blocking effect of Nmyc is thus amplified by chromosomal imbalances of the downstream mediators, Cdc42 and nm23-H1 and nm23-H2. Moreover, neuroblastomas frequently have an unbalanced translocation between chromosomes 1p and 17q, causing loss of heterozygosity of 1p and gain of 17q (32, 33) . This would, by a single hit, disturb the balance between Cdc42 and the nm23 genes. The translocation event is often followed by duplication of the derivative chromosome 1 with the extra 17q material, further increasing the imbalance. Amplification of N-myc would boost the effect of the imbalance, by down-regulation of the remaining Cdc42 copy and up-regulation of the overrepresented nm23 genes. The down-regulation of Cdc42 and up-regulation of the nm23 genes by N-myc is very consistent in neuroblastoma cell lines and tumors. In the two cell lines in which we can manipulate N-myc activity, Cdc42 is down-regulated and the nm23 genes are up-regulated. Furthermore, comparison of a panel of 10 N-myc amplified tumors and 10 N-myc single copy neuroblastomas strongly supports an identical effect of N-myc on Cdc42 and the nm23 genes in vivo (this article and ref. 14) .
The nm23 proteins could function as a GAP for Cdc42, keeping Cdc42 in the inactive, GDP-bound state. Several lines of evidence support this role for nm23-H1. Direct GAP activity of nm23-H1 was shown for the Rad1 GTPase in melanoma cells (20) . Involvement in the regulation of Cdc42-family member Rac1 was established as well. Nm23-H1 is recruited toward adhesive junctions by ARF6-GTP (34) . At these junctions, nm23-H1 negatively regulates TIAM1 and subsequently Rac1 is inactivated (21) . In this study, we showed that nm23-H1 can bind to the Cdc42 protein and nm23 can inhibit the Cdc42-induced differentiation. These data suggest that nm23-H1 and nm23-H2 also exerts GAP-activity for Cdc42.
Is Cdc42 the elusive neuroblastoma suppressor gene at distal chromosome 1p? If Cdc42 indeed functions as a tumor suppressor gene, it would be unlikely to be the only 1p suppressor gene in neuroblastoma. Deletions of 1p in N-myc amplified neuroblastomas are at least 24.4 Mb. If Cdc42, which maps at 21.5 Mb from the telomere, would be the one and only suppressor gene, a certain frequency of interstitial deletions encompassing Cdc42 would be expected. The length of the deletions has previously raised the idea that more than one suppressor gene is involved (5) . Thus far, only one homozygous 1p36 deletion was identified in a neuroblastoma cell line (35) . The scarcity of homozygous 1p36 deletions in N-myc amplified neuroblastomas has suggested that the postulated tumor suppressor gene(s) may function by haploinsufficiency. Our data suggest that Cdc42 may represent the first example of such a gene. The chromosome 17q region gained in neuroblastoma tumors is also very large. Therefore, in addition to the nm23 genes, other 17q genes may contribute to neuroblastoma pathogenesis as well.
Neuroblastomas are embryonal tumors that originate from neural crest-derived cells. During normal embryogenesis N-myc is expressed in migrating neuroblasts (36) and probably prevents premature differentiation. When neuroblasts arrive at their destination in the trunk, N-myc expression ceases and differentiation proceeds, in which the Cdc42/nm23 pathway may play an important role. The strong differentiation-inducing potential of Cdc42 and the suppression of this effect by N-myc and nm23 suggest that this is a major mechanism in neuroblast differentiation. We therefore consider Cdc42 as a strong candidate tumor suppressor gene for neuroblastoma. The classic proof of principle for a tumor suppressor gene is inactivation of both gene copies. One copy of Cdc42 is deleted, but we detected no mutations in the remaining copy. Our siRNA experiments showed that a minimal Cdc42 activity is required for viability of neuroblastoma cells, explaining why Cdc42 cannot be homozygously inactivated. Down-regulation of Cdc42 by siRNA caused a major reduction in cell number and dislocation of actin to the inner surface of rounded cells. Normally, this is only observed during cell division and should be followed by actin rearrangent and the appearance of new stress fibers. Absence of Cdc42 causes a collapse of the cytoskeleton and might thus inhibit cell cycle progression. Alternatively, the observed cell death may result from the involvement of Cdc42 in spindle formation and cell cycle progression by the Cdc42-PAR6-PKC3 pathway, as observed in Caenorhabditis elegans and rat astrocytes (37, 38) . Surprisingly, SHEP-21N cells treated with siRNA still show many metaphases after 72 hours. This phenotype resembles the yeast Cdc42-V44A mutant, which cannot interact with multiple effector proteins (39) . Half of these mutant cells have two or more nuclei, indicating a G 2 -M-phase delay and a defect in cytokinesis and cell separation.
The mechanism of inactivation of Cdc42 might represent a new paradigm for tumor suppressor gene inactivation. Chromosomal regions that consistently show hemizygosity or moderate copy number gains are frequent in human tumors. For many of them, no tumor suppressor genes or oncogenes have been identified as yet. Here we show that these relatively limited changes in copy numbers can dramatically amplify the oncogenic effect of an activated pathway, in this case the N-myc pathway. Importantly, in this model the actual tumor suppressor gene does not have to be completely inactivated. Cdc42 is not fully destroyed like classic tumor suppressor genes but can be reactivated. This offers a clinical perspective, as innovative drugs may interfere in the pathway and restore the function of the remaining Cdc42 allele.
